Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands

Kwakman, J.J.M.; Vink, G.; Vestjens, J.H.; Beerepoot, L.V.; Groot, J.W. de; Jansen, R.L.; ... ; Koopman, M. (2018)

Article / Letter to editor

• Trifluridine/tipiracil
• TAS-102
• Metastatic colorectal cancer
• Compassionate use
• Feasibility

• All authors: Kwakman, J.J.M.; Vink, G.; Vestjens, J.H.; Beerepoot, L.V.; Groot, J.W. de; Jansen, R.L.; Opdam, F.L.; Boot, H.; Creemers, G.J.; Rooijen, J.M. van; M. los; Vulink, A.J.E.; Schut, H.; Meerten, E. van; Baars, A.; Hamberg, P.; Kapiteijn, E.; Sommeijer, D.W.; Punt, C.J.A.; Koopman, M.
• Date: 2018-06-30
• Journal: International Journal of Clinical Oncology
• Volume: 23
• Issue: 3
• Pages: 482 - 489
• DOI: doi:10.1007/s10147-017-1220-0